RheumNow Podcast – ACR 20 is Coming to Town (10.30.20)
Dr Jack Cush overviews the RheumNow commitment, upcoming bonus coverage of ACR20 and the good news and journal reports from the past week on RheumNow.com
FDA Hearing on COVID-19 Vaccines
Yesterday the Food and Drug Administration's (FDA) "Vaccines and Related Biological Products Advisory Committee" conve
RheumNow Podcast – Back Talk: Questions from Listeners (10.23.20)
Dr. Jack Cush reviews the news, journal reports, survey results and "Back Talk" questions from Rheums.
Remdesivir FDA Approved for Hospitalized COVID-19
The FDA has approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States.
Clinical Trial Boom or Bust in Severe COVID-19
A number of recently published clinical trials are further defining the efficacy and outcomes of tocilizumab or remdesivir in treating SARs-CoV-2 infection.
Remdesivir
Outpatient Visits Return to Pre-COVID Rates
The COVID-19 pandemic dramatically impacted outpatient care - numbers, scope, quality, etc, but a recent study suggests that while COVID has changed the scope of care, the numbers of outpatient visits have risen to near pre-pandemic numbers.
RheumNow Podcast – Good Time Charlie…. (10.16.20)
Dr. Jack Cush sings the news and journal reports from the past week on RheumNow.com.
COVID Transmission from Young to Old
The CDC has analyzed temporal trends in percent positivity by age group in COVID-19 hotspot counties before and after their identification as hotspots.
Hydroxychloroquine Shows No Benefit in Hospitalized COVID-19 Patients
The NEJM reports on a controlled clinical trial showing patients hospitalized with Covid-19 given hydroxychloroquine (HCQ) do not have a lower incidence of death compared to those receiving routine care.
RheumNow Podcast – Bad Disease & Bad Outcomes (10.9.20)
Dr. Jack Cush Reviews the news and journal articles from the past week on RheumNow.com.
Systemic Steroids Reduce Mortality in COVID-19
JAMA Internal Medicine reports an analysis of COVID-19 clinical trials showing that critically ill patients with COVID-19 treated with systemic corticosteroids have an overall lower mortality rate.
RheumNow Podcast – Function Follows Form (10.2.20)
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.
Social
Safety of COVID-19 Vaccines in Rheumatic Patients
A multinational study shows that the use of COVID vaccination in rheumatic and musculoskeletal disease (I-RMD) is safe, well-tolerated with very rare serious adverse events (AEs).
https://t.co/d30zbfa0f8 https://t.co/OM6GzAzTvQ
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
Does COVID Vax reduce adolescent MIS-C risk? In France 77% of teens recv COVID Vaccine by 10/2021. From Sept-Oct 2021,107 MIS-C kids were hospitalized in France; 31% were eligible but not vaccinated. MIS-C risk dropped 91% (0.09) after 1st first vax dose https://t.co/mF0L2VnEoi https://t.co/R33n1FCN3X
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
Best of 2021: Israel provides COVID vaccine answers for rheumatic disease patients
https://t.co/3mWEjdAnLL https://t.co/It5VjbQMoI
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
We're now learning about the T-cell response to Omicron after an mRNA vaccine boosters. That's why these new findings in people with multiple sclerosis on immunosuppressive therapy are very encouraging
https://t.co/Gzv9sQTsuA https://t.co/SoezeVWgR3
Eric Topol @EricTopol ( View Tweet )
2 years 3 months ago
listen to my take on how out pt mgmnt for #immunocompromised pts can be optimized & how we MUST protect them fr #COVID19 @VuMedi linkhttps://bit.ly/3FfdYGB
@RheumNow
@NatalieEAzarMD
@BolekBerqui
@KDAO2011
@rhjeumn
@CreakyJoints
@AWIRGROUP
@RNSociety
@RheumAPP https://t.co/hKVIg8Aw2g
Leonard Calabrese @LCalabreseDO ( View Tweet )
2 years 3 months ago
Third Time's the Charm - COVID Vaccination While on Rituximab
https://t.co/3j0KeQtzw1 https://t.co/YvgpaDX7tv
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
ICYMI: Update on Safety, Effectiveness of SARS-CoV-2 vaccines in SLE
https://t.co/ihWapOaiNO https://t.co/daoIZtpsHH
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
COVID-19 in Patients with Primary Systemic Vasculitis and Polymyalgia Rheumatica
Dr. Bella Mehta ( @bella_mehta) interviews Dr. Sebastian Sattui about abstract #0952 presented at the #ACR21 annual meeting.
https://t.co/BYyz0Xj1Fj
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
COVID-19 Vaccination in Autoimmune Disease: Dr. Sheila Reyes ( @RHEUMarampa) interviews Dr. Latika Gupta about abstract #0444, presented at the #ACR21 annual meeting.
https://t.co/yFqj3fAtrW https://t.co/idWis7FURI
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
Love this COVID ARDS risk calculator put forth by @JYazdanyMD at #ACR21 for our patient's with Rheumatic Diseases. A wonderful resource in talking to our patients about vaccine necessity! @CleClinicMD https://t.co/EA5jVYweHm
Emily Littlejohn @ELittlejohnDO ( View Tweet )
2 years 5 months ago
